Found: 4
Select item for more details and to access through your institution.
B‐cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon‐α2, or combination treatment.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 4, p. 351, doi. 10.1111/ejh.13292
- By:
- Publication type:
- Article
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 1, p. 83, doi. 10.1111/ejh.12687
- By:
- Publication type:
- Article
Expansion of circulating CD56<sup>bright</sup> natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 3, p. 227, doi. 10.1111/ejh.12420
- By:
- Publication type:
- Article
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161570
- By:
- Publication type:
- Article